Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Monopar Therapeutics Inc. (MNPR) had Free Cash Flow per Share of $-0.81 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.62M |
|
-- |
|
-- |
|
$3.22M |
|
$-3.22M |
|
$0.60M |
|
$-2.62M |
|
$-2.62M |
|
$-2.62M |
|
$-2.62M |
|
$-2.62M |
|
$-2.62M |
|
$-3.22M |
|
$-3.22M |
|
6.99M |
|
6.99M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$55.08M |
|
-- |
|
$0.01M |
|
$55.09M |
|
$1.49M |
|
-- |
|
-- |
|
$1.49M |
|
$53.59M |
|
$53.59M |
|
$53.59M |
|
6.12M |
|
| Cash Flow Statement Financials | |
$-5.66M |
|
$-0.33M |
|
$-0.12M |
|
$45.82M |
|
$39.71M |
|
$-6.10M |
|
$1.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
36.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.90% |
|
-4.90% |
|
-4.77% |
|
-4.90% |
|
$8.76 |
|
|
Free Cash Flow per Share |
$-0.81 |
$-0.81 |
|